Events

Medical Device Connectivity: HIPAA, FDA and IP Considerations

Events / Wednesday, June 14, 2017

On Wednesday, June 14, 2017, BakerHostetler hosted a complimentary CLE webinar: Medical Device Connectivity: HIPAA, FDA and IP Considerations

With increasing healthcare costs and the transition to value-based reimbursement, never has the need for connected medical devices been so great – and never have the pitfalls been so daunting. Join us for an overview of the regulatory and intellectual property landscape for this groundbreaking technology.

Our speakers summarized developments in compliance and security issues, FDA guidelines for premarket and postmarket management of cybersecurity, as well as FDA rules regarding software for medical devices and software as a medical device (SaMD).

In addition, IP considerations such as claim drafting strategies, design patents for GUIs and recommendations for layered protection of patient monitoring inventions were also discussed.

Presented by:
  • Hussein Akhavannik focuses his practice on portfolio management, patent prosecution and IP due diligence. He prosecutes patent applications in technologies related to the electrical, computer, medical and mechanical arts. Hussein spent almost four years at the U.S. Patent and Trademark Office as a patent examiner and as a legal intern for the Patent Trial and Appeal Board and the Office of the Solicitor.
  • With a background as a defense, regulatory, and registered patent attorney who has also worked as a registered pharmacist, Lee Rosebush provides his clients with legal counsel that is grounded in first-hand experience. Lee is frequently sought out to help expedite corporate deals involving healthcare entities.
Presentation Materials >>
Recording

For questions, contact Natalia Egan at 216.430.2941.

Related Industries

Blog

In The Blogs

Previous Next
Health Law Update
Capitol Hill Healthcare Update
November 13, 2017
SENATE COMMITTEES TO REVIEW TRUMP’S HHS PICK The year-end schedules of the Senate HELP and Finance committees just became more clogged, as the two panels will lead the review of President Trump’s nominee to be Health & Human Services (HHS)...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
November 6, 2017
December Most Likely Timetable for CHIP Even After House Approval The House last week voted to renew the Children’s Health Insurance Program (CHIP) through 2022, but disagreements over how to pay for the program are likely to delay...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
October 30, 2017
House Plans CHIP Vote This Week but Final Action Not Likely Until December House Majority Leader Kevin McCarthy (R-Calif.) said lawmakers will vote this week on legislation to renew federal funding for the Children’s Health Insurance...
Read More ->
Health Law Update
Physicians in the Bulls-eye
October 25, 2017
Several recently reported cases highlight the growing risk physicians face if they succumb to competitive pressures, especially offers of remuneration from labs, pharmacies, home health agencies and other providers to whom they refer. In...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
October 23, 2017
White House Eyes Panel on Drug Prices While Senators Call for Transparency President Donald Trump is considering appointing lawmakers to a bipartisan commission that would develop strategies to lower prescription drug prices, while...
Read More ->